Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Hot vs Cold: the differences between tumor types

Cancer Classification

Hypoxia Markers and Their Importance

The Biochemistry of Breast Cancer Screening

Why are Cancer Cell Lines Useful?

Insights into Oncofertility

Overview of Cell Viability and Cytotoxicity

Cancer Research

What is Cancer?

What is the Tumor Microenvironment?

Acidosis and Tumor Progression

See more featured articles »

Cancer Pain

What Role do Biobanks Play in Cancer Research?

Cancer Symptoms

What is Merkel Cell Carcinoma?

What is Immunochemotherapy?

Investigating the Molecular Mechanisms of Cancer

Microfluidic cancer treatment screen combined with flow cytometry

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Cancer Pathophysiology

Cancer Prognosis

Myc Mutations and Cancer

Is Cancer a Metabolic Disorder?

Pediatric Cancer

The Cancer Cell Surface Proteome as a Therapeutic Target

Living with Cancer Pain

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Management

Assay for Monitoring and Treating Malignant Brain Tumors

Cancer Pain Management

Targeted Cancer Therapies

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Secondary Brain Cancer

Extracellular Vesicles as Floating Cancer Biomarkers

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Metastatic Migration in Cancer may be Influenced by Metabolism

Transforming Cancer Care through Genomic Testing

Cancer Prevention: Lowering your Risk

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Diagnosis

Insight into Cancer Vaccines

Secondary Lung Cancer

What Causes Cancer?

What is Tumorigenesis?

Cancer Glossary

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer History

Cutaneous Manifestations of Internal Malignancy

Cancer Epidemiology

CDK9 and Cancer

British Pioneers in Cancer Biology

Caring for a Loved One with Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Using Biomarkers to Detect Cancer

The Effects of Cancer on Family Life

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What is Cancer of Unknown Primary?

TARDIS: The Improved Method of Detecting Breast Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Latest Cancer News and Research

Pomegranate phytobiotics offer natural alternative to synthetic veterinary drugs

Researchers have identified a broad range of biological properties in pomegranate with potential for use in medical applications, including antimicrobial, antiparasitic, antioxidant, immunomodulatory, antidiabetic, anti-inflammatory, liver-supporting, and wound-healing effects.

27 Aug 2026

Unexpected discovery points to a possible route for childhood brain tumor treatments

When researchers at Lund University investigated how the molecule UM171 works, a molecule used to make blood stem cells multiply, they made an unexpected connection.

27 Aug 2026

CAR T-cell therapy successfully reverses severe rheumatoid arthritis

Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific therapies, manufactured from patients' own immune cells, could also help cure autoimmune diseases.

27 Aug 2026

Scalable stem cell method advances off-the-shelf CAR-T therapies

Researchers at the Center for Regenerative Medicine (CReM) at Boston Medical Center (BMC) and Boston University (BU) have developed a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs), overcoming a longstanding challenge in the development of stem cell-based immunotherapies.

27 Aug 2026

Unscreened cervical cancer rates rise dangerously over past 20 years

The percentage of women in their 20s who have never been screened for cervical cancer has been increasing at a disturbing rate over the past 20 years – to the point that now, almost a third of women between the ages of 21 and 29 have never been screened.

27 Aug 2026

Biosimilars reduce financial burden for cancer patients and insurers

Biologic drugs play an important role in treating cancers such as breast cancer and lymphoma, but their high costs can add to the financial burden of cancer care.

27 Aug 2026

Salk researchers isolate specific neurons controlling complex social behaviors

Our brains constantly integrate information about both our internal state and our surroundings to determine how we behave.

27 Aug 2026

Alliance releases new film highlighting the critical role of clinical trials

The Alliance for Clinical Trials in Oncology has released a film highlighting the critical role of participant involvement in advancing cancer research and improving care.

27 Aug 2026

UMass Amherst researcher wins $2.5 million to expand nanoparticle cancer vaccine study

Having established the effectiveness of her nanoparticle drug-delivery system for cancer immunotherapy, University of Massachusetts Amherst researcher Prabhani Atukorale, has been awarded $2.5 million from the National Institutes of Health to broaden the scope of her vaccine research to include treating those with active cancer.

27 Aug 2026

New mutant rat model replicates human chronic kidney disease

Chronic kidney disease (CKD) is a major health burden affecting approximately one in ten adults globally. Even with improved treatments, many patients continue to have worsening loss of kidney function, resulting in the need for dialysis or transplantation.

27 Aug 2026

Fleeting interactions between membrane sugar chains control cell division

Acting as an armor, a scaffold, and a communication platform in one, our cells' plasma membrane lies at the heart of many crucial cellular processes.

27 Aug 2026

Study challenges traditional breast cancer classification methods

Breast cancer is often classified as either estrogen receptor-positive (hormone-sensitive) or not. However, a new study from Karolinska Institutet suggests that this simplified classification may overlook important biological differences between patients that could affect treatment decisions.

27 Aug 2026

New funding backs pioneering research to make brain cancer treatment more effective

Adelaide researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against tumors, while reducing damage to healthy tissue.

27 Aug 2026

UofL receives new federal funding to advance metabolic health research

Chronic health conditions such as diabetes, obesity, heart disease and metabolic liver disease have sharply increased in recent decades and are among the most urgent health challenges facing our society.

27 Aug 2026

Computer model could streamline design of protein degraders

A team of Weill Cornell Medicine investigators has developed a computer model that will help scientists more efficiently develop protein-destroying therapies, a newer type of treatment that is particularly promising for cancer.

27 Aug 2026

Study reveals why diffuse midline glioma develops in brain midline regions

Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to the H3.3 K27M, a mutation in the histone H3.3 protein that drives many cases of diffuse midline glioma (DMG), depending on the cell's location in the developing brain.

27 Aug 2026

FDA approves first RAS-targeted therapy for metastatic pancreatic cancer

The U.S. Food and Drug Administration (FDA) has approved daraxonrasib, an oral multi-selective RAS(ON) inhibitor, for adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy.

27 Aug 2026

New study tracks global colorectal cancer risk across 185 nations

Colorectal cancer has long been recognized as a major global health threat, but its burden is far from evenly distributed. Incidence and mortality rates vary dramatically across countries, and these differences are closely tied to socioeconomic development, dietary transitions, and the adoption of screening programs.

26 Aug 2026

New review examines oral cancer drug delivery barriers and strategies

Delivering drugs directly to oral tumor sites remains challenging. A recent review involving researchers from Hasanuddin University examines barriers to local drug delivery and analyses strategies for targeting oral cancer lesions.

26 Aug 2026

Real-world Chinese study confirms benefits of niraparib maintenance therapy for ovarian cancer

Ovarian cancer remains one of the most lethal gynecologic malignancies worldwide, with a high risk of recurrence even after successful initial treatment.

26 Aug 2026